Repligen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Repligen and other ETFs, options, and stocks.

About RGEN

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America.

CEO

Olivier Dominique Loeillot

CEOOlivier Dominique Loeillot

Employees

1,778

Employees1,778

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

1981

Founded1981

Employees

1,778

Employees1,778

RGEN Key Statistics

Market cap

6.97B

Market cap6.97B

Price-Earnings ratio

-301.31

Price-Earnings ratio-301.31

Dividend yield

—

Dividend yield—

Average volume

776.82K

Average volume776.82K

High today

—

High today—

Low today

—

Low today—

Open price

$123.00

Open price$123.00

Volume

0.00

Volume0.00

52 Week high

$182.52

52 Week high$182.52

52 Week low

$102.97

52 Week low$102.97

Analyst ratings

76%

of 21 ratings

Buy

76.2%

Hold

23.8%

Sell

People also own

Based on the portfolios of people who own RGEN. This list is generated using Robinhood data, and it’s not a recommendation.